Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| December 12th, 2024 |
Limited Competition: Continued Development of INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed) |
National Institutes of Health |
| September 28th, 2026 |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
National Institutes of Health |
| September 28th, 2026 |
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
National Institutes of Health |
| October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) |
National Institutes of Health |
| February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional) |
National Institutes of Health |
| February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional) |
National Institutes of Health |
| October 20th, 2027 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 26th, 2025 |
Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 1st, 2025 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| October 16th, 2026 |
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 17th, 2025 |
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) |
National Institutes of Health |
| June 2nd, 2027 |
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) |
National Institutes of Health |
| June 2nd, 2027 |
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2028 |
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
National Institutes of Health |
| October 23rd, 2025 |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
National Institutes of Health |
| October 20th, 2025 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) |
National Institutes of Health |
| October 20th, 2025 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) |
National Institutes of Health |
|
| January 7th, 2028 |
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 23rd, 2025 |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 14th, 2026 |
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
| July 14th, 2026 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| January 28th, 2027 |
Translational Neural Devices (R61/R33 - Clinical Trial Optional) |
National Institutes of Health |
| January 27th, 2027 |
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) |
National Institutes of Health |
| March 31st, 2025 |
Support strengthening and utilization of strategic information activities in the Republic of South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control-GHC |
| January 7th, 2028 |
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 15th, 2027 |
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 1st, 2027 |
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 1st, 2027 |
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 1st, 2027 |
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 16th, 2027 |
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) |
National Institutes of Health |
| January 10th, 2025 |
Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| January 31st, 2025 |
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) |
National Institutes of Health |
| November 5th, 2027 |
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) |
National Institutes of Health |
